Intact Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.3M | Buy |
3,200
+100
| +3% | +$40.5K | 0.04% | 210 |
|
2025
Q1 | $1.54M | Buy |
3,100
+500
| +19% | +$249K | 0.05% | 194 |
|
2024
Q4 | $1.35M | Buy |
2,600
+660
| +34% | +$343K | 0.05% | 200 |
|
2024
Q3 | $1.2M | Sell |
1,940
-420
| -18% | -$260K | 0.04% | 194 |
|
2024
Q2 | $1.31M | Buy |
2,360
+260
| +12% | +$144K | 0.05% | 189 |
|
2024
Q1 | $1.22M | Sell |
2,100
-200
| -9% | -$116K | 0.05% | 193 |
|
2023
Q4 | $1.22M | Buy |
+2,300
| New | +$1.22M | 0.05% | 188 |
|
2023
Q1 | – | Sell |
-2,000
| Closed | -$1.1M | – | 276 |
|
2022
Q4 | $1.1M | Sell |
2,000
-700
| -26% | -$385K | 0.05% | 177 |
|
2022
Q3 | $1.37M | Sell |
2,700
-100
| -4% | -$50.7K | 0.05% | 182 |
|
2022
Q2 | $1.52M | Hold |
2,800
| – | – | 0.05% | 175 |
|
2022
Q1 | $1.66M | Buy |
2,800
+200
| +8% | +$118K | 0.04% | 185 |
|
2021
Q4 | $1.74M | Sell |
2,600
-1,000
| -28% | -$667K | 0.04% | 185 |
|
2021
Q3 | $2.06M | Sell |
3,600
-200
| -5% | -$114K | 0.06% | 166 |
|
2021
Q2 | $1.92M | Hold |
3,800
| – | – | 0.05% | 167 |
|
2021
Q1 | $1.74M | Hold |
3,800
| – | – | 0.05% | 175 |
|
2020
Q4 | $1.77M | Sell |
3,800
-400
| -10% | -$186K | 0.06% | 180 |
|
2020
Q3 | $1.85M | Hold |
4,200
| – | – | 0.06% | 169 |
|
2020
Q2 | $1.52M | Hold |
4,200
| – | – | 0.06% | 168 |
|
2020
Q1 | $1.19M | Hold |
4,200
| – | – | 0.05% | 172 |
|
2019
Q4 | $1.36M | Buy |
4,200
+2,100
| +100% | +$682K | 0.05% | 173 |
|
2019
Q3 | $612K | Hold |
2,100
| – | – | 0.02% | 188 |
|
2019
Q2 | $617K | Hold |
2,100
| – | – | 0.02% | 185 |
|
2019
Q1 | $575K | Buy |
2,100
+100
| +5% | +$27.4K | 0.02% | 182 |
|
2018
Q4 | $447K | Hold |
2,000
| – | – | 0.02% | 183 |
|
2018
Q3 | $488K | Hold |
2,000
| – | – | 0.02% | 192 |
|
2018
Q2 | $414K | Hold |
2,000
| – | – | 0.01% | 190 |
|
2018
Q1 | $413K | Hold |
2,000
| – | – | 0.02% | 185 |
|
2017
Q4 | $380K | Buy |
+2,000
| New | +$380K | 0.02% | 172 |
|